Avidity biosciences announces addition to the nasdaq biotechnology index

La jolla, calif., dec. 21, 2020 /prnewswire/ -- avidity biosciences, inc. (nasdaq: rna), a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called antibody oligonucleotide conjugates (aocs™), today announced that it has been added to the nasdaq...

RNA Ratings Summary

RNA Quant Ranking